Prosecution Insights
Last updated: April 19, 2026

Recor Medical, Inc.

8 pending office actions • 1 client

Portfolio Summary

8
Total Pending OAs
0
Final Rejections
8
Non-Final OAs

Client Portfolio (1 client)

Client (Assignee)Pending OAs
Otsuka Medical Devices Co., Ltd. 8

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18662757 TISSUE TREATMENT SYSTEMS AND METHODS WITH ACOUSTIC DOSE MANAGEMENT Otsuka Medical Devices Co., Ltd. HOFFA, ANGELA MARIE 3799 Non-Final OA May 13, 2024
18659628 TISSUE TREATMENT CATHETER HAVING PORT BRACE Otsuka Medical Devices Co., Ltd. CWERN, JONATHAN 3797 Non-Final OA May 09, 2024
18407306 CATHETERS WITH BALLOONS ON WHICH ARE LOCATED ELECTRODES Otsuka Medical Devices Co., Ltd. COLLINS, SEAN W 3794 Non-Final OA Jan 08, 2024
18481220 DEVICES, METHODS AND SYSTEMS FOR RENAL DENERVATION Otsuka Medical Devices Co., Ltd. LANCASTER, LINDSAY REGAN 3794 Non-Final OA Oct 04, 2023
18451044 AIR-BACKED TRANSDUCERS FOR ULTRASOUND DENERVATION AND METHODS AND SYSTEMS THAT USE AIR-BACKED TRANSDUCERS Otsuka Medical Devices Co., Ltd. ROSENAU, DEREK JOHN 2837 Non-Final OA Aug 16, 2023
18327280 METHODS, DEVICES AND SYSTEMS THAT USE ONE OR MORE TRANSDUCERS TO HEAT NERVES TO EVOKE NEURAL RESPONSE WITHOUT DENERVATING NERVES, AS WELL AS TO DENERVATE NERVES Otsuka Medical Devices Co., Ltd. BLAISE, BRADFORD CHRISTOPHER 3794 Non-Final OA Jun 01, 2023
18182821 USING CHARACTERISTICS OF NATIVE OR EVOKED SENSED NEURAL ACTIVITY TO SELECT DENERVATION PARAMETERS Otsuka Medical Devices Co., Ltd. ZIEGLER, ABIGAIL M 3794 Non-Final OA Mar 13, 2023
17817540 THERAPEUTIC ULTRASOUND TISSUE TREATMENT SYSTEMS, APPARATUSES, AND METHODS Otsuka Medical Devices Co., Ltd. RHODES, NORA W 3794 Non-Final OA Aug 04, 2022

Managing Recor Medical, Inc.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month